Karl Beutner
Founder at DermBiont, Inc.
Profile
Karl R.
Beutner is the founder of DermBiont, Inc. (founded in 2017) where he holds the title of President, Chief Executive Officer & Director.
He is also the founder of Solano Clinical Research.
Dr. Beutner's current job is as a Professor at the University of California, Berkeley.
His former jobs include being the Medical Director at Oclassen Pharmaceuticals, Inc., Chief Medical Officer & Vice President at Dow Pharmaceutical Sciences, Inc., and Chief Medical Officer & Senior Vice President at Anacor Pharmaceuticals LLC.
Dr. Beutner's education includes an undergraduate degree from St. Mary's College of California and graduate and doctorate degrees from the State University of New York at Buffalo.
Karl Beutner active positions
| Companies | Position | Start |
|---|---|---|
| University of California, Berkeley | Corporate Officer/Principal | - |
| Solano Clinical Research | Founder | 2010-09-12 |
DermBiont, Inc.
 DermBiont, Inc. Miscellaneous Commercial ServicesCommercial Services DermBiont, Inc. operates as an early stage biopharmaceutical company that engages in discovery and development of live bacterial products for the treatment of skin diseases. It develops skin microbiome therapeutics platform to treat and prevent skin diseases. The company was founded by Karl R. Beutner, Robert M. Brucker and Nichola Eliovits in 2017 and is headquartered in Boston, MA. | Founder | 2016-12-31 |
Former positions of Karl Beutner
| Companies | Position | End |
|---|---|---|
Dow Pharmaceutical Sciences, Inc.
 Dow Pharmaceutical Sciences, Inc. Medical DistributorsDistribution Services Dow Pharmaceutical Sciences, Inc. develops and distributes topical drug products. The firm provides product development services including formulation and regulatory consulting, formulation optimization utilizing state-of-the-art in vitro permeation models, full analytical support, cGMP clinical manufacturing and clinical labeling. The company was founded by Gordon J. Dow in 1977 and is headquartered in Petaluma, CA. | Chief Tech/Sci/R&D Officer | 2004-12-31 |
Oclassen Pharmaceuticals, Inc.
 Oclassen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Oclassen Pharmaceuticals Inc, headquartered in San Rafael, CA develops and markets specialty pharmaceuticals for the prevention, diagnosis and treatment of skin diseases. Oclassen Pharmaceuticals develops and markets products for the dermatology and wound-care markets. | Chief Tech/Sci/R&D Officer | - |
| ANACOR PHARMACEUTICALS INC | Chief Tech/Sci/R&D Officer | - |
Training of Karl Beutner
| St. Mary's College of California | Undergraduate Degree |
| State University of New York at Buffalo | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Oclassen Pharmaceuticals, Inc.
Oclassen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Oclassen Pharmaceuticals Inc, headquartered in San Rafael, CA develops and markets specialty pharmaceuticals for the prevention, diagnosis and treatment of skin diseases. Oclassen Pharmaceuticals develops and markets products for the dermatology and wound-care markets. | Health Technology |
Dow Pharmaceutical Sciences, Inc.
Dow Pharmaceutical Sciences, Inc. Medical DistributorsDistribution Services Dow Pharmaceutical Sciences, Inc. develops and distributes topical drug products. The firm provides product development services including formulation and regulatory consulting, formulation optimization utilizing state-of-the-art in vitro permeation models, full analytical support, cGMP clinical manufacturing and clinical labeling. The company was founded by Gordon J. Dow in 1977 and is headquartered in Petaluma, CA. | Distribution Services |
Anacor Pharmaceuticals LLC
 Anacor Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Anacor Pharmaceuticals, Inc. develops medical solutions. The firm operates as a biopharmaceutical company, which focuses on discovering, developing, and commercializing novel small-molecule therapeutics derived from its boron chemistry platform. The company was founded by Lucy Shapiro, Stephen J. Benkovic, and David P. Perry in 2000 and is headquartered in Palo Alto, CA. | Health Technology |
| Solano Clinical Research | |
DermBiont, Inc.
DermBiont, Inc. Miscellaneous Commercial ServicesCommercial Services DermBiont, Inc. operates as an early stage biopharmaceutical company that engages in discovery and development of live bacterial products for the treatment of skin diseases. It develops skin microbiome therapeutics platform to treat and prevent skin diseases. The company was founded by Karl R. Beutner, Robert M. Brucker and Nichola Eliovits in 2017 and is headquartered in Boston, MA. | Commercial Services |
- Stock Market
- Insiders
- Karl Beutner
